Reconciling innate and acquired immunity in atopic dermatitis
- 1 April 2020
- journal article
- editorial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 145 (4) , 1136-1137
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Atopic dermatitis endotypes and implications for targeted therapeuticsJournal of Allergy and Clinical Immunology, 2019
- Tissue signals imprint ILC2 identity with anticipatory functionNature Immunology, 2018
- Increased frequencies of basophils, type 2 innate lymphoid cells and Th2 cells in skin of patients with atopic dermatitis but not psoriasisJournal of Dermatological Science, 2017
- Innate immunological function of TH2 cells in vivoNature Immunology, 2015
- The Interleukin-33-p38 Kinase Axis Confers Memory T Helper 2 Cell Pathogenicity in the AirwayImmunity, 2015
- Dupilumab Treatment in Adults with Moderate-to-Severe Atopic DermatitisNew England Journal of Medicine, 2014
- A role for IL-25 and IL-33–driven type-2 innate lymphoid cells in atopic dermatitisJournal of Experimental Medicine, 2013
- Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in miceProceedings of the National Academy of Sciences, 2013
- TSLP Elicits IL-33–Independent Innate Lymphoid Cell Responses to Promote Skin InflammationScience Translational Medicine, 2013
- IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditionsProceedings of the National Academy of Sciences, 2002